These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30861189)

  • 1. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
    Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
    J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil inhibits proliferation and collagen synthesis and induces apoptosis of human fibroblasts derived from urethral scar via the Rho/ROCK signaling pathway.
    Xu N; Chen SH; Qu GY; Li XD; Lin W; Xue XY; Lin YZ; Zheng QS; Wei Y
    Am J Transl Res; 2017; 9(3):1317-1325. PubMed ID: 28386357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasudil inhibits actin polymerization and collagen synthesis and induces apoptosis in human urethral scar fibroblasts via the Rho/ROCK pathway.
    Li XD; Wu YP; Chen SH; Liang YC; Lin TT; Lin T; Wei Y; Xue XY; Zheng QS; Xu N
    Drug Des Devel Ther; 2018; 12():2707-2713. PubMed ID: 30214158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rho kinase inhibitor (Fasudil) suppresses TGF-β mediated autophagy in urethra fibroblasts to attenuate traumatic urethral stricture (TUS) through re-activating Akt/mTOR pathway: An in vitro study.
    Feng H; Huang X; Fu W; Dong X; Yang F; Li L; Chu L
    Life Sci; 2021 Feb; 267():118960. PubMed ID: 33373654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
    Zhou Y; Su J; Shi L; Liao Q; Su Q
    Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.
    Zhou H; Zhang KX; Li YJ; Guo BY; Wang M; Wang M
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):387-94. PubMed ID: 21457293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fasudil inhibits HSC adhesion, migration and proliferation via Rho/ROCK pathway].
    Wang YZ; Jiang HQ; Hu CX; Chen X
    Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):821-3. PubMed ID: 17125608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.
    Fukushima M; Nakamuta M; Kohjima M; Kotoh K; Enjoji M; Kobayashi N; Nawata H
    Liver Int; 2005 Aug; 25(4):829-38. PubMed ID: 15998434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of manipulation on cartilage in rats with knee osteoarthritis based on the Rho-associated protein kinase/LIM kinase 1/Cofilin signaling pathways.
    Xiao G; Yunhao Y; Dongmei L; Fang P; Zhixue Y; Zhengwei Z; Ao L; Chenglin T
    J Tradit Chin Med; 2022 Apr; 42(2):194-199. PubMed ID: 35473339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
    Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
    Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
    Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
    Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
    J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
    Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
    Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
    Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
    Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro.
    Tura A; Grisanti S; Petermeier K; Henke-Fahle S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2152-61. PubMed ID: 17460274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
    Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
    Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase.
    Bond JE; Kokosis G; Ren L; Selim MA; Bergeron A; Levinson H
    Plast Reconstr Surg; 2011 Nov; 128(5):438e-450e. PubMed ID: 22030503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
    Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
    Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.